Aesica is granted a Certificate of Suitability for Flurbiprofen
Aesica Pharmaceuticals has been granted a Certificate of Suitability for Flurbiprofen by the European Directorate for the Quality of Medicines (EDQM). The certificate, number R0-CEP 2003-270-Rev 00, was awarded on the 24th March 2006 and confirms that Aesica's Flurbiprofen is compliant with the requirements of the European Pharmacopoeial monograph. Further details of the certificate can be found on the EDQM website or by contacting our Regulatory Affairs department [email ; ashleigh.gordon@aesica-pharma.com].
